Janus Henderson Group’s Coherus Oncology, Inc. Common Stock CHRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-26,496
| Closed | -$88.4K | – | 2536 |
|
|
2023
Q4 | $88.4K | Buy |
26,496
+18
| +0.1% | +$60 | ﹤0.01% | 2533 |
|
|
2023
Q3 | $99.2K | Buy |
26,478
+86
| +0.3% | +$322 | ﹤0.01% | 2520 |
|
|
2023
Q2 | $112K | Sell |
26,392
-27
| -0.1% | -$115 | ﹤0.01% | 2557 |
|
|
2023
Q1 | $181K | Buy |
26,419
+14,493
| +122% | +$99.2K | ﹤0.01% | 2518 |
|
|
2022
Q4 | $94.4K | Sell |
11,926
-11,926
| -50% | -$94.4K | ﹤0.01% | 2345 |
|
|
2022
Q3 | $228K | Buy |
23,852
+11,934
| +100% | +$114K | ﹤0.01% | 2343 |
|
|
2022
Q2 | $86K | Buy |
11,918
+1
| +0% | +$7 | ﹤0.01% | 2496 |
|
|
2022
Q1 | $154K | Buy |
11,917
+2
| +0% | +$26 | ﹤0.01% | 2496 |
|
|
2021
Q4 | $190K | Buy |
+11,915
| New | +$190K | ﹤0.01% | 2405 |
|
|
2021
Q3 | – | Sell |
-19,224
| Closed | -$266K | – | 2199 |
|
|
2021
Q2 | $266K | Buy |
19,224
+451
| +2% | +$6.24K | ﹤0.01% | 1544 |
|
|
2021
Q1 | $274K | Sell |
18,773
-487,276
| -96% | -$7.11M | ﹤0.01% | 1417 |
|
|
2020
Q4 | $8.8M | Sell |
506,049
-1,018,538
| -67% | -$17.7M | ﹤0.01% | 881 |
|
|
2020
Q3 | $28M | Buy |
1,524,587
+649,603
| +74% | +$11.9M | 0.01% | 639 |
|
|
2020
Q2 | $15.6M | Buy |
+874,984
| New | +$15.6M | 0.01% | 746 |
|